Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression

被引:124
作者
Borrego, S
Sáez, ME
Ruiz, A
Gimm, O
López-Alonso, M
Antiñolo, G
Eng, C
机构
[1] Hosp Univ Virgen del Rocio, Unidad Genet Med & Diagnost Prenatal, Seville 41013, Spain
[2] Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Univ Cambridge, CRC, Human Canc Genet Res Grp, Cambridge, England
关键词
polymorphism; low penetrance alleles; neurocristopathy; chromosome; 10;
D O I
10.1136/jmg.36.10.771
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hirschsprung disease (HSCR) is a common genetic disorder presenting with functional intestinal obstruction secondary to enteric aganglionosis. HSCR can be familial or sporadic. Although five putative susceptibility genes have been identified, only germline mutations in the RET proto-oncogene account for a significant minority (up to 50%) of familial HSCR; 3% of sporadic HSCR in a population based series carry RET mutations. From 1998 to February 1999, we prospectively ascertained 64 cases of sporadic HSCR fi om the western Andalusia region. To determine if polymorphic sequence variants within RET could act as low penetrance predisposing alleles, we examined allelic frequencies at seven polymorphic loci in this population based series. Whether allele frequencies differed from those in the control population were determined by either chi-squared analysis or Fisher's exact test. For two sequence variants, A45A (c 135G-->A) (exon 2) and L769L (c 2307T-->G) (exon 13), the rarer polymorphic allele was over-represented among HSCR cases versus controls (p<0.0006). In contrast, two other polymorphisms, G691S (c 2071C-->A) (exon 11) and S904S (c 2712C-->G) (exon 15), were under-represented in the HSCR patients compared to controls (p=0.02). Polymorphisms in the RET proto-oncogene appear to predispose to HSCR in a complex, low penetrance fashion and may also modify phenotypic expression.
引用
收藏
页码:771 / 774
页数:4
相关论文
共 24 条
  • [1] MUTATION ANALYSIS OF THE RET RECEPTOR TYROSINE KINASE IN HIRSCHSPRUNG DISEASE
    ANGRIST, M
    BOLK, S
    THIEL, B
    PUFFENBERGER, EG
    HOFSTRA, RM
    BUYS, CHCM
    CASS, DT
    CHAKRAVARTI, A
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (05) : 821 - 830
  • [2] DIVERSITY OF RET PROTOONCOGENE MUTATIONS IN FAMILIAL AND SPORADIC HIRSCHSPRUNG DISEASE
    ATTIE, T
    PELET, A
    EDERY, P
    ENG, C
    MULLIGAN, LM
    AMIEL, J
    BOUTRAND, L
    BELDJORD, C
    NIHOULFEKETE, C
    MUNNICH, A
    PONDER, BAJ
    LYONNET, S
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (08) : 1381 - 1386
  • [3] BADNER JA, 1990, AM J HUM GENET, V46, P568
  • [4] Bolk S., 1996, American Journal of Human Genetics, V59, pA213
  • [5] Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease
    Borrego, S
    Eng, C
    Sánchez, B
    Sáez, ME
    Navarro, E
    Antiñolo, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) : 3361 - 3364
  • [6] CECCHERINI I, 1994, ONCOGENE, V9, P3025
  • [7] MUTATIONS OF THE RET PROTOONCOGENE IN HIRSCHSPRUNGS-DISEASE
    EDERY, P
    LYONNET, S
    MULLIGAN, LM
    PELET, A
    DOW, E
    ABEL, L
    HOLDER, S
    NIHOULFEKETE, C
    PONDER, BAJ
    MUNNICH, A
    [J]. NATURE, 1994, 367 (6461) : 378 - 380
  • [8] RET proto-oncogene in the development of human cancer
    Eng, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 380 - 393
  • [9] POINT MUTATION WITHIN THE TYROSINE KINASE DOMAIN OF THE RET PROTOONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B AND RELATED SPORADIC TUMORS
    ENG, C
    SMITH, DP
    MULLIGAN, LM
    NAGAI, MA
    HEALEY, CS
    PONDER, MA
    GARDNER, E
    SCHEUMANN, GFW
    JACKSON, CE
    TUNNACLIFFE, A
    PONDER, BAJ
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (02) : 237 - 241
  • [10] Eng C, 1997, HUM MUTAT, V9, P97, DOI 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.3.CO